Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Pathogenesis of holoprosencephaly
Xin Geng, Guillermo Oliver
Xin Geng, Guillermo Oliver
Published June 1, 2009
Citation Information: J Clin Invest. 2009;119(6):1403-1413. https://doi.org/10.1172/JCI38937.
View: Text | PDF
Science in Medicine

Pathogenesis of holoprosencephaly

  • Text
  • PDF
Abstract

Holoprosencephaly (HPE), the most common human forebrain malformation, occurs in 1 in 250 fetuses and 1 in 16,000 live births. HPE is etiologically heterogeneous, and its pathology is variable. Several mouse models of HPE have been generated, and some of the molecular causes of different forms of HPE and the mechanisms underlying its variable pathology have been revealed by these models. Herein, we summarize the current knowledge on the genetic alterations that cause HPE and discuss some important questions about this disease that remain to be answered.

Authors

Xin Geng, Guillermo Oliver

×

Figure 5

Mechanistic model of telencephalon development in normal and HPE conditions.

Options: View larger image (or click on image) Download as PowerPoint
Mechanistic model of telencephalon development in normal and HPE conditi...
(A) Model of normal mammalian telencephalic development. On the left side, the PrCP is represented by a white rectangle. The blue square around it highlights those steps known to be critical in the pathogenesis of alobar HPE. Toward the right side of the diagram, genes known to be important during subsequent steps of forebrain development are indicated. The orange rectangle highlights steps and genes important for semilobar HPE, the green rectangle highlights those important for MIH, and the gray rectangle highlights those important for microforms of HPE. Solid lines represent those processes that have been demonstrated and dashed lines represent those processes that have not yet been directly proved. To better understand the regional relationships between some of those critical genes, their normal expression patterns in the telencephalon at E9.0 and E10.5 are illustrated in B and C, respectively. C is adapted with permission from Journal of Neuropathology and Experimental Neurology (106). Hnf3b, hepatocyte nuclear factor 3β; Otx2, orthodenticle homolog 2; Pax6, paired box gene 6; Wnt8b, wingless-related MMTV integration site 8b.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts